Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 1 non-open-market transaction below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Feb. 9, 2012 ACNT A 2,380 · · 2,380 Direct · Acquired (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Feb. 9, 2012 ACNT Employee Stock Option (right to buy) Common Stock (2,380) $11.34 Feb. 9, 2022 2,380 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 2 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
May 2, 2011 ACNT Common Stock 17,290 Direct
May 2, 2011 ACNT Common Stock 3,047 Indirect

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

ACNT

President, Manufacturers Chemicals, LLC(4)
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2012 · · · · · · · ·
2011 · · · · · · · ·

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.